{"id":1699,"date":"2023-02-21T14:45:16","date_gmt":"2023-02-21T13:45:16","guid":{"rendered":"https:\/\/dextechmedical.com\/?page_id=1699"},"modified":"2024-03-25T15:00:28","modified_gmt":"2024-03-25T14:00:28","slug":"executive-board","status":"publish","type":"page","link":"https:\/\/dextechmedical.com\/en\/about-dextech\/executive-board\/","title":{"rendered":"Executive Board"},"content":{"rendered":"<hr \/>\n<p><strong>Anders R Holmberg \u2013 Founder and CEO<\/strong><\/p>\n<p>Anders R Holmberg is the founder and CEO of DexTech. Holmberg holds a PhD from Uppsala University and is a chemical engineer. Holmberg is a specialist in glycosylation chemistry and has over 30 years of experience in this field including process development. He worked at Pharmacia Corporation from 1978 to 1997. Holmberg was also Director of Development at MAP Medical Applied Products AB\/Oy, 1999-2003, and CEO of MAP AB, 2001-2003. Anders R Holmberg is behind about 50 of them. published scientific articles.<\/p>\n<p><strong>Year of birth:<\/strong> 1951<br \/>\n<strong>Position since:<\/strong> CEO since 2004-08-09<br \/>\n<strong>Number of shares:<\/strong> 1,573,227 shares privately<\/p>\n<hr \/>\n<p><strong>Sten Nilsson \u2013 Founder<\/strong><\/p>\n<p>Sten Nilsson, born in 1948, is the founder of DexTech. PhD, PhD, Professor of Oncology. Nilsson is an internationally recognized authority in urological oncology, especially prostate cancer. After over 30 years of clinical experience, he has access to a large international network. Nilsson works as a professor and chief physician at Radiumhemmet. Through his profession, Sten Nilsson has daily contact with the clinical reality for prostate patients. He also has extensive experience of clinical studies with new drugs, where he has been involved in designing and conducting Algeta\/Bayer&#8217;s phase I, II and III studies of Alpharadin\/Xofigo. Sten Nilsson has published more than 200 copies. scientific articles.<\/p>\n<p><strong>Year of birth:<\/strong> 1948<br \/>\n<strong>Number of shares:<\/strong> 1,432,724 shares privately<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Anders R Holmberg \u2013 Founder and CEO Anders R Holmberg is the founder and CEO of DexTech. Holmberg holds a PhD from Uppsala University and is a chemical engineer. Holmberg [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":240,"menu_order":31,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1699","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Executive Board | DexTech<\/title>\n<meta name=\"description\" content=\"Anders R Holmberg \u2013 Founder and CEO Anders R Holmberg is the founder and CEO of DexTech. Holmberg holds a PhD from Uppsala University and is a chemical\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dextechmedical.com\/en\/about-dextech\/executive-board\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Executive Board | DexTech\" \/>\n<meta property=\"og:description\" content=\"Anders R Holmberg \u2013 Founder and CEO Anders R Holmberg is the founder and CEO of DexTech. Holmberg holds a PhD from Uppsala University and is a chemical\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dextechmedical.com\/en\/about-dextech\/executive-board\/\" \/>\n<meta property=\"og:site_name\" content=\"DexTech\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-25T14:00:28+00:00\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/dextechmedical.com\/en\/about-dextech\/executive-board\/\",\"url\":\"https:\/\/dextechmedical.com\/en\/about-dextech\/executive-board\/\",\"name\":\"Executive Board | DexTech\",\"isPartOf\":{\"@id\":\"https:\/\/dextechmedical.com\/#website\"},\"datePublished\":\"2023-02-21T13:45:16+00:00\",\"dateModified\":\"2024-03-25T14:00:28+00:00\",\"description\":\"Anders R Holmberg \u2013 Founder and CEO Anders R Holmberg is the founder and CEO of DexTech. Holmberg holds a PhD from Uppsala University and is a chemical\",\"breadcrumb\":{\"@id\":\"https:\/\/dextechmedical.com\/en\/about-dextech\/executive-board\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/dextechmedical.com\/en\/about-dextech\/executive-board\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/dextechmedical.com\/en\/about-dextech\/executive-board\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/dextechmedical.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"About DexTech\",\"item\":\"https:\/\/dextechmedical.com\/en\/about-dextech\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Executive Board\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/dextechmedical.com\/#website\",\"url\":\"https:\/\/dextechmedical.com\/\",\"name\":\"DexTech\",\"description\":\"Ett svenskt forskningsf\u00f6retag specialiserat p\u00e5 urologisk onkologi fr\u00e4mst prostatacancer\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/dextechmedical.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Executive Board | DexTech","description":"Anders R Holmberg \u2013 Founder and CEO Anders R Holmberg is the founder and CEO of DexTech. Holmberg holds a PhD from Uppsala University and is a chemical","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dextechmedical.com\/en\/about-dextech\/executive-board\/","og_locale":"en_US","og_type":"article","og_title":"Executive Board | DexTech","og_description":"Anders R Holmberg \u2013 Founder and CEO Anders R Holmberg is the founder and CEO of DexTech. Holmberg holds a PhD from Uppsala University and is a chemical","og_url":"https:\/\/dextechmedical.com\/en\/about-dextech\/executive-board\/","og_site_name":"DexTech","article_modified_time":"2024-03-25T14:00:28+00:00","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dextechmedical.com\/en\/about-dextech\/executive-board\/","url":"https:\/\/dextechmedical.com\/en\/about-dextech\/executive-board\/","name":"Executive Board | DexTech","isPartOf":{"@id":"https:\/\/dextechmedical.com\/#website"},"datePublished":"2023-02-21T13:45:16+00:00","dateModified":"2024-03-25T14:00:28+00:00","description":"Anders R Holmberg \u2013 Founder and CEO Anders R Holmberg is the founder and CEO of DexTech. Holmberg holds a PhD from Uppsala University and is a chemical","breadcrumb":{"@id":"https:\/\/dextechmedical.com\/en\/about-dextech\/executive-board\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dextechmedical.com\/en\/about-dextech\/executive-board\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/dextechmedical.com\/en\/about-dextech\/executive-board\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dextechmedical.com\/en\/"},{"@type":"ListItem","position":2,"name":"About DexTech","item":"https:\/\/dextechmedical.com\/en\/about-dextech\/"},{"@type":"ListItem","position":3,"name":"Executive Board"}]},{"@type":"WebSite","@id":"https:\/\/dextechmedical.com\/#website","url":"https:\/\/dextechmedical.com\/","name":"DexTech","description":"Ett svenskt forskningsf\u00f6retag specialiserat p\u00e5 urologisk onkologi fr\u00e4mst prostatacancer","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dextechmedical.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/pages\/1699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/comments?post=1699"}],"version-history":[{"count":3,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/pages\/1699\/revisions"}],"predecessor-version":[{"id":1933,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/pages\/1699\/revisions\/1933"}],"up":[{"embeddable":true,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/pages\/240"}],"wp:attachment":[{"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/media?parent=1699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}